Free tool
FAERS Monitor: Airduo Digihaler
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208799 or its brand name (Airduo Digihaler, Fluticasone Propionate, Salmeterol Xinafoate). Reports on generic versions are filed under their own applications.
Reports
2,689
Serious
335
12% of reports
Hospitalization
156
Death reported
33
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- product dose omission issue1,561
- off label use280
- product use issue263
- drug ineffective243
- dyspnoea198
- cough98
- wrong technique in product usage process95
- accidental underdose85
- asthma85
- product use in unapproved indication63
- dysphonia53
- headache45
- incorrect dose administered41
- pain38
- wheezing38
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 11 |
| 2018 | 54 |
| 2019 | 50 |
| 2020 | 50 |
| 2021 | 135 |
| 2022 | 233 |
| 2023 | 281 |
| 2024 | 729 |
| 2025 | 383 |
| 2026 | 757 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,470 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| accidental underdoseSignal | 85 | 46.5 | 37.7 | 3,716 |
| product dose omission issueSignal | 1,561 | 41.7 | 40.4 | 62,572 |
| product use issueSignal | 263 | 11.0 | 9.8 | 2,388 |
| dysphoniaSignal | 53 | 7.1 | 5.4 | 272 |
| asthmaSignal | 85 | 5.9 | 4.8 | 342 |
| wheezingSignal | 38 | 5.0 | 3.7 | 118 |
| wrong technique in product usage processSignal | 95 | 3.7 | 3.0 | 183 |
| dyspnoeaSignal | 198 | 2.7 | 2.4 | 222 |
| coughSignal | 98 | 2.7 | 2.3 | 107 |
| off label useSignal | 280 | 2.5 | 2.2 | 262 |
| product use in unapproved indication | 63 | 2.0 | 1.6 | 30 |
| drug ineffective | 243 | 1.4 | 1.3 | 35 |
| incorrect dose administered | 41 | 1.4 | 1.0 | 4 |
| headache | 45 | 0.6 | 0.4 | 15 |
| pain | 38 | 0.5 | 0.4 | 21 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.